Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This study aimed to compare the short-term efficacy of 0.1% nepafenac with that of
0.4% ketorolac tromethamine in patients with low risk factors for cystoid macular
edema (CME) undergoing phacoemulsification.